Literature DB >> 17701925

Human amniotic membrane as a suitable matrix for growth of mouse urothelial cells in comparison with human peritoneal and omentum membranes.

Farzaneh Sharifiaghdas1, Nahid Hamzehiesfahani, Reza Moghadasali, Fatemeh Ghaemimanesh, Hossein Baharvand.   

Abstract

INTRODUCTION: For tissue engineering of the urinary tract system, cell culture requires to be established in vitro and an appropriate matrix acting as cell carrier should be developed. The aim of the present study was to assess the proliferation quality of mouse urothelial cells on 3 natural matrixes of human amniotic membrane (AM), peritoneum, and omentum, and to compare them with collagen matrix.
MATERIALS AND METHODS: Mouse urothelial cells were isolated by collagenase IV, and the urothelial cells (105 cells per milliliter) were cultured on the AM, peritoneum, omentum, and collagen. The pattern of growth and asymmetric unit membrane formation were analyzed by histologic examination and immunocytochemistry on the detached urothelium with pancytokeratin and uroplakin III, respectively. Electron micrographs were taken and cell layers, organelles, desmosomes, and junctions were studied.
RESULTS: Immunocytochemistry of cultivated cells confirmed the urothelial cells phenotype. Up to 4 cell layers were obtained on the AM and 1 to 2 layers on the peritoneum. Distribution of the urothelial cells on the omentum was not favorable, which was due to its large pores. Cell proliferation started later on the AM (7th day) compared to collagen (3rd day). Also, apoptosis started later on the AM (after 14 days) compared to collagen (7 days).
CONCLUSION: These results showed that the AM can act as a cell carrier for culture of the urothelial cells, and its exceptional properties such as having various growth factors, availability, and cost-effectiveness make it a unique biological matrix for urothelial culture.

Entities:  

Mesh:

Year:  2007        PMID: 17701925

Source DB:  PubMed          Journal:  Urol J        ISSN: 1735-1308            Impact factor:   1.510


  7 in total

1.  Amniotic membrane scaffolds enable the development of tissue-engineered urothelium with molecular and ultrastructural properties comparable to that of native urothelium.

Authors:  Urška Dragin Jerman; Peter Veranič; Mateja Erdani Kreft
Journal:  Tissue Eng Part C Methods       Date:  2013-10-12       Impact factor: 3.056

2.  Comparison of a poly-L-lactide-co-ε-caprolactone and human amniotic membrane for urothelium tissue engineering applications.

Authors:  Reetta Sartoneva; Suvi Haimi; Susanna Miettinen; Bettina Mannerström; Anne-Marie Haaparanta; George K Sándor; Minna Kellomäki; Riitta Suuronen; Tuija Lahdes-Vasama
Journal:  J R Soc Interface       Date:  2010-11-24       Impact factor: 4.118

3.  Supportive features of a new hybrid scaffold for urothelium engineering.

Authors:  Mohammad Naji; Javad Rasouli; Nasser Shakhssalim; Mohammad Mehdi Dehghan; Masoud Soleimani
Journal:  Arch Med Sci       Date:  2015-04-23       Impact factor: 3.318

4.  Urethral reconstruction with tissue-engineered human amniotic scaffold in rabbit urethral injury models.

Authors:  Fuli Wang; Tao Liu; Lijun Yang; Geng Zhang; Heliang Liu; Xiaomin Yi; Xiaojian Yang; Tzu-yin Lin; Weijun Qin; Jianlin Yuan
Journal:  Med Sci Monit       Date:  2014-11-26

Review 5.  Applications of Human Amniotic Membrane for Tissue Engineering.

Authors:  Mathilde Fénelon; Sylvain Catros; Christophe Meyer; Jean-Christophe Fricain; Laurent Obert; Frédéric Auber; Aurélien Louvrier; Florelle Gindraux
Journal:  Membranes (Basel)       Date:  2021-05-25

6.  Amniotic Membrane Preparation Crucially Affects Its Broad-Spectrum Activity Against Uropathogenic Bacteria.

Authors:  Taja Železnik Ramuta; Marjanca Starčič Erjavec; Mateja Erdani Kreft
Journal:  Front Microbiol       Date:  2020-03-24       Impact factor: 5.640

7.  Human Amniotic Membrane Enriched with Urinary Bladder Fibroblasts Promote the Re-Epithelization of Urothelial Injury.

Authors:  Urška Dragin Jerman; Peter Veranič; Tina Cirman; Mateja Erdani Kreft
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.